Originally published at mrnasdog.com/research/inj/inflation by MrNasdog.
Injective mints 0.94M INJ per 90 days in staking rewards and burns 0.11M INJ through its monthly Community BuyBack — a net of +0.83% over the last 90 days and +0.90% projected over the next. Our supply monitor reads −0.20% for the same window, a gap of 1.02 percentage points that ships a ⚠ monitor gap chip, because the circulating figure the market quotes for INJ has been pinned at exactly 100M since Nov 11 2025 while real INJ supply reached 127.75M. Injective's burn is real, verifiable and permanent; it is simply about eight times smaller than the mint it is meant to offset.
The verdict, in one paragraph
For the 90-day window ending Aug 16 2026, the MrNasdog Pressure Framework reads INJ at +0.83% net, with +0.90% projected over the next 90 days. Our supply monitor reads −0.20% for the trailing window, a gap of 1.02 percentage points — well outside the framework's 0.5-point tolerance, so a ⚠ monitor gap chip is attached to the overview page. The gap is not a disagreement about Injective's mechanics. It is a frozen denominator: the classified circulating figure has not moved off 100,000,000 INJ for nine months, so a monitor built on it can only ever read rounding noise around zero. Reading both places INJ actually exists — 122.45M as the native token on Injective plus 5.30M still unlocked as an ERC-20 on Ethereum — puts real supply at 127.75M and rising. INJ is structurally inflationary on a mis-stated float: a genuine buyback-and-burn attached to a staking emission it cannot out-run.
Sell pressure: where new INJ comes from
Sell #1 — protocol inflation — is the whole sell ledger for Injective, at 0.94M INJ realised over the last 90 days and 1.01M INJ projected over the next. Injective is an uncapped Cosmos proof-of-stake chain, and staking rewards are the only mechanism in its design that creates INJ. The mint module runs at its 4.4% ceiling because only 47.6% of the token is bonded to validators, comfortably under the 60% bonding target that would let the rate fall back toward its 2.2% floor. That 4.4% is the number every Injective tokenomics page quotes, and it is the number this analysis does not use.
Two corrections separate the headline rate from the realised one, and both were measured on-chain this build rather than assumed. The first is block speed: the mint module divides its annual issuance by a governance parameter of 63,072,000 blocks a year, which assumes a half-second block. Injective actually produced 11,773,912 blocks across the 90-day window, a real interval of 0.66 seconds — so the chain collected about 76% of the blocks the parameter budgets for, and issues proportionally less. The second correction is the base. Staking rewards are struck against the INJ balance held on Injective itself, which sat near 110M for most of the window, not against every INJ in existence. Put together, Injective's realised issuance ran at 2.98% a year on total INJ supply, not 4.40%. The arithmetic was verified end to end: global supply of 126,926,138 INJ on May 18 2026 became 127,751,227 INJ on Aug 16 2026, a rise of 825,089 after burns.
The other three sell rows are zero, each for a structural reason. Sell #2 — vesting unlocks — is zero because Injective's genesis allocation finished unlocking in January 2024; every team, seed, private-sale and ecosystem tranche has already been released, and no cliff exists anywhere in 2026 or beyond. Sell #3 — Foundation and unscheduled unlocks — books zero, and the reason is a double-counting guard rather than an absence of activity, covered below. Sell #4 — long-term locked or bankruptcy — is zero because no estate, trustee or court-administered pool holds INJ at all.
Buy pressure: where new INJ goes
Buy #1 — programmatic buyback — is the only live buy force, at 0.11M INJ in the last 90 days and the same 0.11M INJ projected. Injective's auction module widened its cycle from seven days to 28 days at round 222, and that monthly cycle is the Community BuyBack: participants commit INJ, receive a pro-rata share of the revenue the Injective ecosystem earned that month, and the INJ they committed is permanently burned. Three rounds settled inside the window and the chain records exactly what each destroyed — 39,300 INJ on Jun 10 2026, 43,500 INJ on Jul 8 2026 and 27,400 INJ on Aug 5 2026, totalling 110,200 INJ. This build took those figures from the auction record itself rather than dividing a press-release dollar target by four, and cross-checked the method against Injective's own published total for its first four rounds, 178,338.03 INJ, which the same source reproduces exactly.
The destination question matters more than the amount, and here the answer is clean: the destination is a burn. Committed INJ is destroyed, not swept into a treasury or a staking contract, so there is no accumulation wallet sitting behind the buyback waiting to become future sell pressure — a structural advantage over exchange tokens that buy and hold. Buy #2 — protocol fee burn — is zero, because Injective has no separate base-fee burn; trading and gas revenue is pooled and sold into the monthly buyback, so every INJ the protocol destroys is already counted in Buy #1. Buy #3 — Foundation buy — is zero: the Injective Foundation publishes no purchase programme with an amount or a set schedule, and the one identified corporate buyer, a listed mortgage company running INJ as a treasury asset, last disclosed a purchase on Feb 19 2026, outside this window and on no schedule. Buy #4 — new long-term lock — is zero, because bonding INJ carries a 21-day unbonding wait, which is a delay rather than a lock, and no new escrow was deployed in the window.
Foundation and overhang
Injective has an unusually thin overhang, and this is the strongest fact on its sell side. There are no unscheduled unlocks: the genesis schedule is fully spent, so there is no non-circulating allocation left for anyone to release. The only team-controlled pool readable on-chain is the governance community pool, which held 5,891 INJ at the Aug 17 2026 read. That pool did fire in the window — it stood at 26,696 INJ on Aug 6 2026 and 4,077 INJ a week later, a governance spend of roughly 22,600 INJ — but it is refilled by a 5% slice of the same staking rewards already booked in Sell #1, so booking the outflow again would double-count supply the framework has already charged. It refreshes on a chain read every 24 hours.
Two overhangs are watched but not measurable. The Injective Foundation and its ecosystem fund hold INJ for grants and ecosystem work without publishing a wallet, so their balance is opaque and refreshes on a bi-weekly walk of official disclosure. The listed corporate treasury holding INJ is identified and stakes what it buys, and it refreshes on its own regulated filings. If any of those balances falls between refreshes, the outflow enters Sell #3 at the next refresh. One large balance is deliberately excluded: the bridge contract on Ethereum holds 94.70M INJ locked, but that is user collateral backing the native token, not team-controlled supply, and it belongs in the denominator rather than the overhang list.
How INJ compares to other uncapped proof-of-stake chains
INJ belongs to the class of uncapped continuous-emission proof-of-stake L1s — the Cosmos design family, where a mint module pays validators forever and a bonding-ratio target steers the rate between a floor and a ceiling. Against that class, Injective is on the disciplined end. Its band runs 2.2% to 4.4%, roughly half the 7% to 20% bands the older Cosmos chains shipped with, and it is one of very few in the family with a real destruction mechanism attached at all. The comparison that flatters Injective least is not with its peers but with itself: the buyback removes about one INJ for every nine minted, so the deflationary flywheel the marketing describes is directionally right and an order of magnitude short of net-negative.
Against hard-capped proof-of-work chains, the contrast is structural rather than a matter of degree. A halving chain's issuance falls on a schedule no vote can raise; Injective's can be moved by governance, and was — proposal IIP-617, the "INJ Supply Squeeze," passed on Jan 19 2026 and cut the emission band rather than adding a new burn. Against exchange tokens running quarterly buyback-and-burn, Injective's destruction is the better-designed half and the smaller half: those tokens usually have no issuance at all to offset, so their burns run straight to net-deflationary, while Injective must first out-run a staking mint. And against chains with an EIP-1559-style base-fee burn, Injective is more predictable but less responsive — a fee burn scales with congestion and can flip a chain deflationary in a busy quarter, whereas a monthly buyback is capped by whatever revenue the ecosystem actually produced.
One trait separates INJ from almost everything else in the catalogue: it is a two-chain token. INJ exists as a native denom on Injective and as a fixed 100,000,000-unit ERC-20 on Ethereum, with a bridge that locks one to mint the other. Reading either side alone gives a wrong answer, and in this window it would have given a spectacularly wrong one — about 12.1M INJ bridged from Ethereum onto Injective between Jul 20 2026 and Jul 26 2026, which a native-only read would have booked as roughly thirteen quarters of issuance arriving in six days.
What to watch in the next 90 days
Three Community BuyBack rounds close inside the window — Sep 2 2026, Sep 30 2026 and Oct 28 2026 — and each one's realised burn is the single most direct input to this reading; the three most recent rounds ranged from 27,400 to 43,500 INJ, so the buy row moves with ecosystem revenue and nothing else. The bonding ratio is the second watch line: it sits at 47.6%, and a move above 60% is the only thing that pulls the mint rate down off its ceiling toward the 2.2% floor without a governance vote. Third, watch whether the 12.1M INJ that bridged onto Injective in July stays — the mint base is the on-chain balance, so a migration back to Ethereum would mechanically cut issuance, and this build's forward projection assumes it stays. Fourth, any successor to IIP-617 in Injective governance would re-base the emission band directly. Finally, the classified circulating figure itself: if it is ever unfrozen from 100,000,000, the monitor gap on this page closes without a single thing changing on the chain.
Summary
The MrNasdog Pressure Framework reads INJ as mildly but persistently inflationary: 0.94M INJ minted per 90 days against 0.11M INJ burned, a net of +0.83% realised and +0.90% projected. The structural mechanism is a staking emission pinned at its 4.4% ceiling by a 47.6% bonding ratio, realising 2.98% a year once slow blocks and the real mint base are accounted for, partly offset by a monthly buyback whose destination is a genuine burn with no accumulation wallet behind it. The key risk is not a cliff or an unlock — Injective has neither — but measurement: the circulating figure the market quotes has been frozen at 100M since Nov 11 2025 while real supply reached 127.75M, so every ratio built on it, market cap included, understates the float by roughly a quarter. There is no cap and no ceiling: Injective is uncapped by design, and the only thing that turns it deflationary is a buyback big enough to beat the mint, which today it is not.
MrNasdog Pressure Framework analysis of INJ, Metric 1 — Inflation. Data + explanation only. Not financial advice. Updated Aug 17 2026.
Top comments (0)